DK0806202T3 - Pharmaceutical composition based on stabilized, lipophilic matrices for controlled release of active substances - Google Patents

Pharmaceutical composition based on stabilized, lipophilic matrices for controlled release of active substances

Info

Publication number
DK0806202T3
DK0806202T3 DK97400990T DK97400990T DK0806202T3 DK 0806202 T3 DK0806202 T3 DK 0806202T3 DK 97400990 T DK97400990 T DK 97400990T DK 97400990 T DK97400990 T DK 97400990T DK 0806202 T3 DK0806202 T3 DK 0806202T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
controlled release
stabilized
active substances
composition based
Prior art date
Application number
DK97400990T
Other languages
Danish (da)
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0806202T3 publication Critical patent/DK0806202T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Stabilised lipophilic matrix for controlled release of active agents. Also claimed is a pharmaceutical composition containing the matrix, preferably in the form of a capsule.
DK97400990T 1996-05-06 1997-05-02 Pharmaceutical composition based on stabilized, lipophilic matrices for controlled release of active substances DK0806202T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (en) 1996-05-06 1996-05-06 PHARMACEUTICAL COMPOSITION BASED ON STABILIZED LIPOPHILIC MATRICES FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS

Publications (1)

Publication Number Publication Date
DK0806202T3 true DK0806202T3 (en) 2002-05-06

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97400990T DK0806202T3 (en) 1996-05-06 1997-05-02 Pharmaceutical composition based on stabilized, lipophilic matrices for controlled release of active substances

Country Status (16)

Country Link
EP (1) EP0806202B1 (en)
JP (1) JP3983339B2 (en)
CN (1) CN1171270A (en)
AT (1) ATE212543T1 (en)
AU (1) AU720146B2 (en)
CA (1) CA2204475C (en)
DE (1) DE69710121T2 (en)
DK (1) DK0806202T3 (en)
ES (1) ES2170922T3 (en)
FR (1) FR2748209B1 (en)
HU (1) HU222045B1 (en)
NO (1) NO318227B1 (en)
NZ (1) NZ314740A (en)
PL (1) PL190562B1 (en)
PT (1) PT806202E (en)
ZA (1) ZA973836B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (en) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solid matrix autoemulsionnables a prolonged action.
FR2782006B1 (en) * 1998-08-07 2002-04-19 Gattefosse Ets Sa SUSTAINED RELEASE COMPOSITION CAPABLE OF FORMING MICRO-EMULSION
DE10161078A1 (en) * 2001-12-12 2003-08-28 Achim Goepferich Matrices for the stabilization and controlled release of problem drugs
KR101152470B1 (en) 2003-08-13 2012-06-01 바이오콘 리미티드 - micro-particle fatty acid salt solid dosage formulations for therapeutic agents
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
JP5406529B2 (en) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド Dual controlled release matrix system based on lipophilic vehicle as capsule filler
EP1959935A2 (en) 2005-10-26 2008-08-27 Banner Pharmacaps Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (en) * 2011-12-08 2013-06-17 Nipro Corp Solid pharmaceutical composition and method for producing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (en) * 1994-04-18 1995-10-19 Basf Ag Retard matrix pellets and process for their production
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
HU9700842D0 (en) 1997-06-30
AU720146B2 (en) 2000-05-25
EP0806202B1 (en) 2002-01-30
FR2748209A1 (en) 1997-11-07
EP0806202A1 (en) 1997-11-12
HU222045B1 (en) 2003-04-28
ES2170922T3 (en) 2002-08-16
PL319808A1 (en) 1997-11-10
ATE212543T1 (en) 2002-02-15
JPH1045629A (en) 1998-02-17
PL190562B1 (en) 2005-12-30
CN1171270A (en) 1998-01-28
HUP9700842A1 (en) 1998-08-28
AU1999197A (en) 1997-11-13
CA2204475C (en) 2002-12-03
NO972068D0 (en) 1997-05-05
NO318227B1 (en) 2005-02-21
JP3983339B2 (en) 2007-09-26
DE69710121T2 (en) 2002-11-28
FR2748209B1 (en) 1998-06-05
PT806202E (en) 2002-06-28
NO972068L (en) 1997-11-07
CA2204475A1 (en) 1997-11-06
ZA973836B (en) 1997-12-02
NZ314740A (en) 1998-11-25
DE69710121D1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
DK0643963T3 (en) Biodegradable device for administration of active substances
BR9607752B1 (en) controlled release microcapsule pharmaceutical formulation.
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
WO2004043201A3 (en) Dispenser for the controlled release of volatile substances
ATE383165T1 (en) SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING WATER-INSOLUBLE COMPOUNDS
MY118835A (en) Sustained release compositions and the process for their preparation
DE59310399D1 (en) Prodrugs, their preparation and use as medicines
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
ATE267007T1 (en) PHARMACEUTICAL TABLET SUITABLE FOR RELEASE OF ACTIVE INGREDIENTS IN CONSECUTIVE AND PREDETERMINABLE TIME PERIOD
TR199800743A3 (en) Continuous release polymer mixture matrix for pharmaceutical application.
BR8901900A (en) SYSTEM FOR RELEASING AN ACTIVE SUBSTANCE FOR THE ATMOSPHERE, MATRICES AND PROCESS FOR FORMING AN ACTIVE SUBSTANCE RELEASE RESERVOIR
DE69426382D1 (en) Bioadhesive pharmaceutical composition for the controlled release of active ingredients
IT8719064A0 (en) TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF ACTIVE SUBSTANCES AT SUBSEQUENT TIMES.
NO981638D0 (en) Drug delivery device for two or more active compounds
MX9304710A (en) PHARMACEUTICAL AND / OR COSMETIC COMPOSITION AND ITS USE.
DK0671901T3 (en) Compositions for dispensing fragrances
DK0806202T3 (en) Pharmaceutical composition based on stabilized, lipophilic matrices for controlled release of active substances
DE59907481D1 (en) CONTROLLING RELEASING PHARMACEUTICAL COMPOSITION WITH TILIDINE MESYLATE AS AN ACTIVE SUBSTANCE
ATE247981T1 (en) PHARMACEUTICAL PREPARATION CONTAINING PROTEIN
SE9704400D0 (en) Porous inorganic particles as carriers for drug substances
DE59801987D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PEPTICHEMIO
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE69012031D1 (en) Optically active benzyl alcohol compound and pharmaceutical composition.
HUT54691A (en) Anti-parasitical, insecticide, acaricide and nematocide preparatives containing 13-alkyl-23-imino- and 13-halogenic-23-imino-11-f28249 derivatives and process for producing the active substances